Vitamin B12 Deficiency Alert: Why This Injection Should Be Avoided has become critical after authorities recalled specific batches of Injection SATAMIN. The Directorate of Drugs Control, Punjab, issued a public health warning, citing substandard medicine and adulterated drugs that could harm patients. Mecobalamin injections, including SATAMIN, are widely used for B12 deficiency treatment, but compromised batches pose serious risks.
The recall covers Batch numbers MC24-022, MC24-023, MC24-026, and MC25-001, all Mecobalamin JP 500 mcg, with expiry dates between June 2026 and July 2027. Drug Testing Laboratories Punjab flagged these injections as substandard after quality checks. The Provincial Quality Control Board immediately ordered their withdrawal. Retailers and wholesalers received notice to stop dispensing affected stock and report consumption records.
Health authorities stress the importance of compliance with recall orders. Substandard or adulterated drugs can worsen Vitamin B12 deficiency and trigger unexpected side effects. Patients should verify pharmaceutical product safety and consult doctors before using any injections. Patients must continue B12 deficiency treatment, but they should use safer alternatives like verified oral supplements or approved Mecobalamin injections.
This recall emphasizes the need for strict pharmaceutical quality control. Authorities continue monitoring the market to prevent similar incidents. Public awareness helps protect patients from unsafe medicines. Always check the expiry date of medicine and batch numbers before administration. Quick action from health authorities ensures patient safety and maintains trust in medical products.
